title: The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants.
abstract: The effect of diuretics, mainly chlorthalidone, on serum cholesterol was studied in 7,006 of the Hypertension Detection and Follow-up Program (HDFP) hypertensive patients not on antihypertensive medication at baseline. Several investigators have reported that diuretic therapy increases serum cholesterol in treated subjects. However, data from two long-term studies indicated that no increase in cholesterol occurred after two years of diuretic treatment. In the present study, yearly changes in serum cholesterol in hypertensives treated with diuretics were observed. The results were in agreement with those reported from both short-term and long-term studies, in that a significant increase in cholesterol was observed in six months to one year into the study but not from the second to the fifth year of therapy. In fact, the serum cholesterol levels were the same as baseline values after two years of drug treatment and decreased slightly thereafter. In the untreated group, no change or a decrease in serum cholesterol was observed during the course of the study. The possible causes for changes in serum cholesterol concentration such as regression to the mean, change in body weight, baseline cholesterol concentration, and the action mechanism of diuretic drugs are discussed.
authors.affiliation: Hypertension Detection and Follow-up Program, National Heart, Lung, and Blood Institute, Bethesda, MD 20205.
authors.forename: W R
authors.initials: WR
authors.lastname: Williams
authors.forename: K A
authors.initials: KA
authors.lastname: Schneider
authors.forename: N O
authors.initials: NO
authors.lastname: Borhani
authors.forename: H W
authors.initials: HW
authors.lastname: Schnaper
authors.forename: L M
authors.initials: LM
authors.lastname: Slotkoff
authors.forename: R D
authors.initials: RD
authors.lastname: Ellefson
mesh_terms: D000328:Adult; D000368:Aged; D001835:Body Weight; D002752:Chlorthalidone / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012727:Sex Characteristics; D013997:Time Factors
chemical_list: D002784:Cholesterol; D002752:Chlorthalidone